Phase II Clinical Trials CROs in Asia-Pacific
32 published
32 published CROs match Phase II Clinical Trials in Asia-Pacific.
Locations in this set include India, United States, Australia, United Kingdom, China, and Japan.
Capabilities that show up most often in this set: Biologics (Other), Vaccine, Cell Therapy, Gene Therapy, and Small Molecule.
Matching companies
Accutest Research LaboratoriesIndependent Indian CRO focused on BA/BE studies, Phase II–IV clinical development, and biologics bioanalysis. Operates 262 clinic beds and 21 LC-MS/MS systems across Mumbai and Vadodara.
AvionFull-service CRO specializing in clinical trial management, advanced medical imaging, dosimetry, and data management across oncology, dermatology, and radiopharmaceutical therapies.
BioAgile TherapeuticsISO 9001:2015-certified CRO offering end-to-end clinical research services including Phase I–IV trials, medical writing, biostatistics, data management, and regulatory support across pharmaceuticals, nutraceuticals, devices, and biotech.
ClinActis Pte LtdFull-service CRO delivering clinical trial services across Asia Pacific, with 50+ years of cumulative experience managing Phase I–IV trials and expertise in oncology, cardiovascular, CNS, and infectious disease indications.- Clinical Research Network India Pvt. Ltd.Clinical Research Organization offering Phase I–IV clinical trials, pharmacovigilance, medical writing, regulatory affairs, and data management services with 15+ years of experience across cardiology, oncology, vaccines, and medical devices.
ClinilabsClinilabs is the leading CNS-focused CRO with 25+ years of expertise in neurotherapeutic clinical trials, offering Phase 1–4 trial management, early-phase development, clinical research units, and MedTech device expertise across psychiatry, neurology, substance use, and rare CNS disorders.
Emerald ClinicalGlobal clinical research organization with 25+ years of expertise, headquartered in Singapore with operations across Asia-Pacific, EMEA, and the Americas. Specializes in renal, oncology, cardiovascular, and early-phase research with deep scientific leadership and proven operational excellence.
FortreaFortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.
ICBioICBio is a Bengaluru-based CRO offering bioavailability/bioequivalence studies, phase II–IV clinical trials, and LC-MS/MS bioanalysis. The excerpts cite regulatory approvals from DCGI-CDSCO, ANVISA, and EMA.
ICON plcICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
Innovate ResearchIndian CRO providing end-to-end clinical trial services (Phase I–IV), regulatory support, medical writing, biostatistics, data management, and biospecimen procurement across pharmaceuticals, biologics, medical devices, and nutraceuticals.- JSS Medical ResearchFull-service CRO with over 30 years of experience offering clinical trials, biostatistics, medical writing, and health economics services across all phases of development.
Krescent Medical ResearchFull-service preclinical and clinical CRO supporting pharmaceutical, biotechnology, and medical device companies with trial design, site selection, data management, statistical analysis, and medical writing across Asia-Pacific.
LinicalGlobal, award-winning CRO guiding clinical development from early-phase research to large-scale global studies with 90% client retention.
MPREXMPREX is a contract research organization in Pune, India, specializing in clinical trials in dermatology and claim-substantiation studies for skin and hair care products, with laboratory testing for product efficacy and safety.
NovotechGlobal full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development.
PPDPPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.
PSIPSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.
PerceptiveLeading clinical research organization providing preclinical to late-phase imaging, randomization and trial supply management (RTSM), and eClinical services to the global biopharmaceutical industry.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Markdown mirror: /services/phase-2-clinical-trials/apac.md